Literature DB >> 26846223

[Typical atrial flutter: Diagnosis and therapy].

Dierk Thomas1, Lars Eckardt2, Heidi L Estner3, Malte Kuniss4, Christian Meyer5, Hans-Ruprecht Neuberger6, Philipp Sommer7, Daniel Steven8, Frederik Voss9, Hendrik Bonnemeier10.   

Abstract

Typical, cavotricuspid-dependent atrial flutter is the most common atrial macroreentry tachycardia. The incidence of atrial flutter (typical and atypical forms) is age-dependent with 5/100,000 in patients less than 50 years and approximately 600/100,000 in subjects > 80 years of age. Concomitant heart failure or pulmonary disease further increases the risk of typical atrial flutter.Patients with atrial flutter may present with symptoms of palpitations, reduced exercise capacity, chest pain, or dyspnea. The risk of thromboembolism is probably similar to atrial fibrillation; therefore, the same antithrombotic prophylaxis is required in atrial flutter patients. Acutely symptomatic cases may be subjected to cardioversion or pharmacologic rate control to relieve symptoms. Catheter ablation of the cavotricuspid isthmus represents the primary choice in long-term therapy, associated with high procedural success (> 97 %) and low complication rates (0.5 %).This article represents the third part of a manuscript series designed to improve professional education in the field of cardiac electrophysiology. Mechanistic and clinical characteristics as well as management of isthmus-dependent atrial flutter are described in detail. Electrophysiological findings and catheter ablation of the arrhythmia are highlighted.

Entities:  

Keywords:  Anticoagulation; Cardiac arrhythmia; Catheter ablation; Cavotricuspid isthmus; Supraventricular tachycardia

Mesh:

Substances:

Year:  2016        PMID: 26846223     DOI: 10.1007/s00399-016-0413-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  18 in total

1.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Richard L Page; José A Joglar; Mary A Caldwell; Hugh Calkins; Jamie B Conti; Barbara J Deal; N A Mark Estes; Michael E Field; Zachary D Goldberger; Stephen C Hammill; Julia H Indik; Bruce D Lindsay; Brian Olshansky; Andrea M Russo; Win-Kuang Shen; Cynthia M Tracy; Sana M Al-Khatib
Journal:  J Am Coll Cardiol       Date:  2015-09-24       Impact factor: 24.094

2.  [Guidelines for catheter ablation].

Authors:  Karl-Heinz Kuck; Sabine Ernst; Uwe Dorwarth; Ellen Hoffmann; Heinz Pitschner; Jürgen Tebbenjohanns; Hans Kottkamp
Journal:  Clin Res Cardiol       Date:  2007-11       Impact factor: 5.460

3.  Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Christian Sticherling; Francisco Marin; David Birnie; Giuseppe Boriani; Hugh Calkins; Gheorghe-Andrei Dan; Michele Gulizia; Sigrun Halvorsen; Gerhard Hindricks; Karl-Heinz Kuck; Angel Moya; Tatjana Potpara; Vanessa Roldan; Roland Tilz; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-23       Impact factor: 5.214

4.  Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation Ablation in Atrial Flutter (Triple A) trial.

Authors:  Ralph Schneider; Joerg Lauschke; Tina Tischer; Cindy Schneider; Wolfgang Voss; Felix Moehlenkamp; Aenne Glass; Doreen Diedrich; Dietmar Bänsch
Journal:  Heart Rhythm       Date:  2015-01-28       Impact factor: 6.343

5.  Misleading long post-pacing interval after entrainment of typical atrial flutter from the cavotricuspid isthmus.

Authors:  Dirk Vollmann; William G Stevenson; Lars Lüthje; Christian Sohns; Roy M John; Markus Zabel; Gregory F Michaud
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

Review 6.  [AV nodal reentrant tachycardia. Diagnosis and therapy].

Authors:  Christian von Bary; Lars Eckardt; Daniel Steven; Hans-Ruprecht Neuberger; Roland Richard Tilz; Hendrik Bonnemeier; Dierck Thomas; Thomas Deneke; Heidi L Estner; Malte Kuniss; Armin Luik; Philipp Sommer; Frederik Voss; Christian Meyer; D I Shin; Charalampos Kriatselis
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-12

7.  Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair.

Authors:  Kristina Wasmer; Julia Köbe; Dirk G Dechering; Alex Bittner; Gerold Mönnig; Peter Milberg; Helmut Baumgartner; Günter Breithardt; Lars Eckardt
Journal:  Int J Cardiol       Date:  2013-03-27       Impact factor: 4.164

8.  Incidence and predictors of atrial flutter in the general population.

Authors:  J Granada; W Uribe; P H Chyou; K Maassen; R Vierkant; P N Smith; J Hayes; E Eaker; H Vidaillet
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

9.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

10.  Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.

Authors:  H J Crijns; I C Van Gelder; J H Kingma; P H Dunselman; A T Gosselink; K I Lie
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.